Dr. Reddy’s shares rise over 1% on strategic collaboration with Alvotech for Keytruda Biosimilar
The partnership between Dr. Reddy’s and Alvotech to develop a biosimilar immunotherapy drug could enhance their positions in the rapidly expanding onc...
Read Full Article →